Carbylan completes enrollment for its Phase 3 trial of Hydros-TA in osteoarthritis
9 June 2015 | By Victoria White
Carbylan Therapeutics has completed enrollment of its COR1.1 Phase 3 pivotal trial of Hydros-TA for the treatment of pain associated with osteoarthritis...